GERMS · 2020 · 10 citations · 13 references
MedicineInfectious DiseasesSurgeryAntimicrobial PharmacotherapyCardiothoracic SurgeryMedical MicrobiologyAntifungal AgentsAntifungal PharmacotherapyAntifungal TherapyFungal InfectionsInfective EndocarditisTreatment Of EndocarditisCandida Infection ManagementCandida TherapyHeart Failure ComplicationsInfectious EndocarditisLong-term Antifungal Maintenance TherapyProsthesis-associated Fungal InfectionProsthesis-related CandidiasisProsthetic Valve Management
INTRODUCTION: species is a rare disease representing about 1-2% of all IE cases and carries a high mortality rate. Given the rarity of the disease, there are no clear guidelines on the type and duration of antifungal therapy. Thus, long-term or even life-long antifungal treatment is commonly used. CASE REPORT: IE and persistent candidemia that failed conservative treatment and ultimately developed heart failure. They underwent prosthetic valve replacement and prolonged antifungal treatment with favorable outcome. DISCUSSION: IE commonly occurs in the setting of underlying malignancy, chronic liver disease, previous endocarditis, previous antimicrobial exposure, previous abdominal surgery, intravenous drug use, presence of a central venous catheter, and previous cardiac surgery. Both present patients had undergone a cardiac surgery and had a prosthetic heart valve, while one patient had an underlying autoimmune disease that could be associated with higher risk of IE. In both patients transthoracic ultrasound failed to diagnose IE. In our patients, conservative treatment alone was not enough to control the infection, thus, both patients underwent valve replacement and were subsequently treated with antifungals for 6 weeks. Furthermore, both patients were put on long-term antifungal suppression treatment. CONCLUSIONS: endocarditis mostly relies on experts' opinion, and, thus, future studies focusing on the type and duration of antifungal treatment are required.
13
Infective Endocarditis in the U.S., 1998–2009: A Nationwide Study
David H. Bor, Steffie Woolhandler, Rachel Nardin et al. · PLoS ONE · 2013 · 319 citations · Full text
Michael A. Pfaller, Gary J. Moet, S. A. Messer et al. · Antimicrobial Agents and Chemotherapy · 2010 · 237 citations · Full text
Michael A. Pfaller, Daniel J. Diekema, Michael G. Rinaldi et al. · Journal of Clinical Microbiology · 2005 · 224 citations · Full text
Candida infective endocarditis
John W. Baddley, Daniel K. Benjamin, M. Patel et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2008 · 210 citations · Full text